NVAX

Novavax Inc

NVAX.US novavax.com + Research + Basket
CIK 0001000694
Employees 749
Phone 240 268 2000
Fiscal year end December
IPO Dec 05, 1995
Address 21 Firstfield Road, Gaithersburg, MD, United States, 20878
9.78
-0.87 (-8.17%)
USD · NASDAQ
52-week range
6.20
13.39
Trading at 50% of the 52-week range
Market Cap
1.76B
P/E Ratio
0.00
Forward P/E
2.58
Book Value
-1.16
Div. Yield
N/A
% Institutions
66.68%
% Insiders
5.05%

1 Year

+27.2%

3 Year

+41.9%

10 Year

-66.7%
Description

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Actions

Add an action for NVAX.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. John Charles Jacobs M.B.A. President, CEO & Director 1967
Mr. James Patrick Kelly C.F.A. Executive VP, CFO & Treasurer 1966
Mr. Mark J. Casey Esq., J.D. Executive VP, Chief Legal Officer & Corporate Secretary 1963
Ms. Elaine O'Hara Executive VP & Chief Strategy Officer 1968
Mr. Richard P. Crowley Executive VP & COO 1957
Ms. Naina Zaman Director of Investor Relations NA
Mr. Troy Morgan Esq., J.D. Senior VP, Deputy General Counsel & Chief Compliance Officer 1971
Ms. Erika S. Trahan Associate Director of Investor & Public Relations NA
Mr. Ian J. Watkins Executive VP & Chief Human Resources Officer 1963
Ms. Silvia Taylor M.B.A. Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Dec 31, 2024 James F Young N/A Sale 5.40K $8.00 $43.20K SEC
Dec 24, 2024 James F Young N/A Sale 4.60K $8.48 $39.01K SEC
Dec 13, 2024 Rachel K King N/A Sale 4.15K $9.02 $37.43K SEC
Jun 21, 2024 James F Young N/A Sale 7.50K $14.09 $105.68K SEC
Jun 18, 2024 James F Young N/A Sale 7.50K $13.72 $102.90K SEC
May 14, 2024 Filip Dubovsky N/A Sale 47.31K $13.90 $657.64K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 13.95M Jun 30, 2026 8.46% $0.00 8.58%
Shah Capital Management 12.17M Sep 30, 2026 7.38% $21.74 -14.06%
State Street Corp 11.74M Jun 30, 2026 7.12% $0.00 30.88%
Vanguard Portfolio Management, LLC 7.61M Jun 30, 2026 4.61% $0.00 6.38%
Vanguard Capital Management, LLC 7.26M Jun 30, 2026 4.40% $0.00 1.79%
Sanofi 6.88M Jun 30, 2026 4.17% $12.14 0.00%
D. E. Shaw & Co LP 5.65M Jun 30, 2026 3.43% $0.03 -26.71%
Geode Capital Management, LLC 4.21M Jun 30, 2026 2.55% $0.00 7.93%
Two Sigma Investments LLC 4.09M Jun 30, 2026 2.48% $0.03 565.43%
Coatue Management LLC 3.84M Jun 30, 2026 2.33% $0.07 0.00%
Bank of America Corp 3.42M Jun 30, 2026 2.07% $0.00 -48.53%
The Goldman Sachs Group Inc 3.01M Jun 30, 2026 1.82% $0.00 113.40%
UBS Group AG 1.87M Jun 30, 2026 1.13% $0.00 -58.25%
Millennium Management LLC 1.77M Jun 30, 2026 1.07% $0.01 -54.10%
Citadel Advisors Llc 1.70M Jun 30, 2026 1.03% $0.00 50.86%
Allianz Asset Management AG 1.58M Jun 30, 2026 0.96% $0.01 -15.09%
Northern Trust Corp 1.45M Jun 30, 2026 0.88% $0.00 -4.06%
TSP Capital Management Group/LLC 1.43M Sep 30, 2026 0.87% $3.90 0.92%
Charles Schwab Investment Management Inc 1.35M Jun 30, 2026 0.82% $0.00 -1.96%
Vanguard Fiduciary Trust Co 1.09M Jun 30, 2026 0.66% $0.00 -1.99%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 5.20M 3.15% ▲ 0.00% Sep 30, 2026
2 State Street® SPDR® S&P® Biotech ETF 4.81M 2.92% ▼ 0.80% Oct 29, 2026
3 iShares Russell 2000 ETF 3.90M 2.36% ▼ 0.41% Oct 29, 2026
4 Vanguard Small Cap Index 3.71M 2.25% ▼ 1.81% Sep 30, 2026
5 Vanguard MStar Small Cap Growth Indx Inv 2.07M 1.25% ▼ 4.55% Sep 30, 2026
6 Fidelity Small Cap Index 1.67M 1.01% ▲ 0.86% Jul 31, 2026
7 iShares Russell 2000 Value ETF 1.43M 0.87% ▼ 0.31% Oct 28, 2026
8 Invesco Biotechnology & Genome ETF 1.23M 0.75% ▲ 0.00% Oct 30, 2026
9 iShares Biotechnology ETF 1.22M 0.74% ▼ 0.19% Oct 29, 2026
10 PIMCO RAE US Small Instl 1.02M 0.62% ▼ 21.75% Jun 30, 2026

Financial Highlights

▼
Market Cap: $1.76B
EBITDA: $-101.55M
PEG Ratio: $1.32
Book Value: $-1.16
Earnings/Share: $-1.74
Profit Margin: -59.87%
Operating Margin: -89.61%
ROA (TTM): -6.51%
ROE (TTM): -898.20%
Revenue (TTM): $413.80M
Revenue/Share (TTM): $2.54
Earnings Growth (YOY): -38.10%
Revenue Growth (YOY): -76.30%

Valuation Metrics

Enterprise Value: $1.15B
Trailing P/E: 0.00
Forward P/E: 2.58

Shares Statistics

Shares Outstanding: 164.95M
Shares Float: 146.21M
% Insiders: 5.05%
% Institutions: 66.68%
Shares Short: 47.35M
Shares Short (Prior Month): 46.05M
Short Ratio: 5.77
Short % Float: 28.89%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$1.12B
Cost of Goods Sold
adjust
$-71.14M
Gross Profit
subtotal
$1.05B
SG&A
adjust
$-157.48M
R&D
adjust
$-336.82M
Operating Income
subtotal
$563.27M
Other / Non-Operating Items
adjust
$-122.97M
Net Income
subtotal
$440.30M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NVAX.US!